Shruti Purohit
Research Subjects
Shruti Purohit has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Leelavati Narlikar
Departments of Data Science and of Biology, Indian Institute of Science Education and Research, Pune, 411008, India
2 shared publications - Satyajeet Khare
Symbiosis School of Biological Sciences (SSBS), Symbiosis International (Deemed University), India
2 shared publications - Tejaswini Pachpor
Department of Biosciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, India
2 shared publications - Vasudeo Paralikar
Dept. of Psychiatry, KEM Hospital, KEM Hospital Research Centre, Pune, Maharashtra, India
2 shared publications - Vipul Vilas Wagh
Symbiosis School of Biological Sciences, Symbiosis International (Deemed University), Pune, MH, India
2 shared publications - Suchita Agrawal
Psychiatry Unit, KEM Hospital Research Centre
1 shared publication
Latest Publications
- Open Access
- 1 May 2024
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 20, 923-936
Ensemble Learning for Higher Diagnostic Precision in Schizophrenia Using Peripheral Blood Gene Expression Profile
Introduction: Stigma contributes to a significant part of the burden of schizophrenia (SCZ), therefore reducing false positives from the diagnosis would be liberating for the individuals with SCZ and desirable for the clinicians. The stigmatization associated with schizophrenia advocates the need for high-precision diagnosis. In this study, we present an ensemble learning-based approach for high-precision diagnosis of SCZ using peripheral blood gene expression profiles. Methodology: The machine learning (ML) models, support vector machines (SVM), and prediction analysis for microarrays (PAM) were developed using differentially expressed genes (DEGs) as features. The SCZ samples were classified based on a voting ensemble classifier of SVM and PAM. Further, microarray-based learning was used to classify RNA sequencing (RNA-Seq) samples from our case-control study (Pune-SCZ) to assess cross-platform compatibility. Results: Ensemble learning using ML models resulted in a significantly higher precision of 80.41% (SD: 0.04) when compared to the individual models (SVM-radial: 71.69%, SD: 0.04 and PAM 77.20%, SD: 0.02). The RNA sequencing samples from our case-control study (Pune-SCZ) resulted in a moderate precision (59.92%, SD: 0.05). The feature genes used for model building were enriched for biological processes such as response to stress, regulation of the immune system, and metabolism of organic nitrogen compounds. The network analysis identified RBX1, CUL4B, DDB1, PRPF19, and COPS4 as hub genes. Conclusion: In summary, this study developed robust models for higher diagnostic precision in psychiatric disorders. Future efforts will be directed towards multi-omic integration and developing “explainable” diagnostic models.
- 1 May 2024
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 20, 923-936
Open AccessEnsemble Learning for Higher Diagnostic Precision in Schizophrenia Using Peripheral Blood Gene Expression Profile
Introduction: Stigma contributes to a significant part of the burden of schizophrenia (SCZ), therefore reducing false positives from the diagnosis would be liberating for the individuals with SCZ and desirable for the clinicians. The stigmatization associated with schizophrenia advocates the need for high-precision diagnosis. In this study, we present an ensemble learning-based approach for high-precision diagnosis of SCZ using peripheral blood gene expression profiles. Methodology: The machine learning (ML) models, support vector machines (SVM), and prediction analysis for microarrays (PAM) were developed using differentially expressed genes (DEGs) as features. The SCZ samples were classified based on a voting ensemble classifier of SVM and PAM. Further, microarray-based learning was used to classify RNA sequencing (RNA-Seq) samples from our case-control study (Pune-SCZ) to assess cross-platform compatibility. Results: Ensemble learning using ML models resulted in a significantly higher precision of 80.41% (SD: 0.04) when compared to the individual models (SVM-radial: 71.69%, SD: 0.04 and PAM 77.20%, SD: 0.02). The RNA sequencing samples from our case-control study (Pune-SCZ) resulted in a moderate precision (59.92%, SD: 0.05). The feature genes used for model building were enriched for biological processes such as response to stress, regulation of the immune system, and metabolism of organic nitrogen compounds. The network analysis identified RBX1, CUL4B, DDB1, PRPF19, and COPS4 as hub genes. Conclusion: In summary, this study developed robust models for higher diagnostic precision in psychiatric disorders. Future efforts will be directed towards multi-omic integration and developing “explainable” diagnostic models.
- Open Access
Ensemble learning for higher diagnostic precision in schizophrenia using peripheral blood gene expression profile
The need for molecular biomarkers for schizophrenia has been well recognized. Peripheral blood gene expression profiling and machine learning (ML) tools have recently become popular for biomarker discovery. The stigmatization associated with schizophrenia advocates the need for diagnostic models with higher precision. In this study, we propose a strategy to develop higher-precision ML models using ensemble learning. We performed a meta-analysis using peripheral blood expression microarray data. The ML models, support vector machines (SVM), and prediction analysis for microarrays (PAM) were developed using differentially expressed genes as features. The ensemble of SVM-radial and PAM predicted test samples with a precision of 81.33% (SD: 0.078). The precision of the ensemble model was significantly higher than SVM-radial (63.83%, SD: 0.081) and PAM (66.89%, SD: 0.097). The feature genes identified were enriched for biological processes such as response to stress, response to stimulus, regulation of the immune system, and metabolism of organic nitrogen compounds. The network analysis of feature genes identified PRF1, GZMB, IL2RB, ITGAL , and IL2RG as hub genes. Additionally, the ensemble model developed using microarray data classified the RNA-Sequencing samples with moderately high precision (72.00%, SD: 0.08). The pipeline developed in this study allows the prediction of a single microarray and RNA-Sequencing sample. In summary, this study developed robust models for clinical application and suggested ensemble learning for higher diagnostic precision in psychiatric disorders. Research highlights: Ensemble learning of Support Vector Machines (SVM) and Prediction Analysis for Microarrays (PAM) algorithms classified schizophrenia samples with higher precision. The pipeline developed in this analysis produced robust models with the ability to classify single microarray sample. Cross-platform validation of ensemble model using RNA-Sequencing data resulted in high precision. Graphical Blood based SCZ diagnosis using ensemble learning for higher precision
Open AccessEnsemble learning for higher diagnostic precision in schizophrenia using peripheral blood gene expression profile
The need for molecular biomarkers for schizophrenia has been well recognized. Peripheral blood gene expression profiling and machine learning (ML) tools have recently become popular for biomarker discovery. The stigmatization associated with schizophrenia advocates the need for diagnostic models with higher precision. In this study, we propose a strategy to develop higher-precision ML models using ensemble learning. We performed a meta-analysis using peripheral blood expression microarray data. The ML models, support vector machines (SVM), and prediction analysis for microarrays (PAM) were developed using differentially expressed genes as features. The ensemble of SVM-radial and PAM predicted test samples with a precision of 81.33% (SD: 0.078). The precision of the ensemble model was significantly higher than SVM-radial (63.83%, SD: 0.081) and PAM (66.89%, SD: 0.097). The feature genes identified were enriched for biological processes such as response to stress, response to stimulus, regulation of the immune system, and metabolism of organic nitrogen compounds. The network analysis of feature genes identified PRF1, GZMB, IL2RB, ITGAL , and IL2RG as hub genes. Additionally, the ensemble model developed using microarray data classified the RNA-Sequencing samples with moderately high precision (72.00%, SD: 0.08). The pipeline developed in this study allows the prediction of a single microarray and RNA-Sequencing sample. In summary, this study developed robust models for clinical application and suggested ensemble learning for higher diagnostic precision in psychiatric disorders. Research highlights: Ensemble learning of Support Vector Machines (SVM) and Prediction Analysis for Microarrays (PAM) algorithms classified schizophrenia samples with higher precision. The pipeline developed in this analysis produced robust models with the ability to classify single microarray sample. Cross-platform validation of ensemble model using RNA-Sequencing data resulted in high precision. Graphical Blood based SCZ diagnosis using ensemble learning for higher precision